|
|
||||||||
1 Diabetes Unit, Section of Endocrinology, Boston Medical Center and Department of Medicine, Boston University School of Medicine, Boston, Massachusetts 02118; and 2 Department de Bioquímica i Biologia Molecular, Facultat de Biologia, Universitat de Barcelona, 08028 Barcelona, Spain
| |
ABSTRACT |
|---|
|
|
|---|
Over the past 30 years, a considerable body of evidence has revealed that a prior bout of exercise can increase the ability of insulin to stimulate glucose transport and glycogen synthesis in skeletal muscle. Apart from its clinical implications, this work has led to a considerable effort to determine at a molecular level how exercise causes this effect and, in particular, whether it does so by enhancing specific events in the insulin-signaling cascade. The objective of this review is to discuss from a historical perspective how our current thinking in this area has evolved and the people responsible for it. Areas to be discussed include the effect or lack of effect of prior exercise on the insulin-signaling pathway, effects of exercise on the regulation by insulin of the GLUT-4 glucose transporter in muscle, and the emerging role of AMP-activated protein kinase as a mediator of exercise-induced signaling events. In addition, we will discuss briefly some of the avenues that research in this area is likely to follow.
diabetes; glucose transport; 5-aminoimidazole-4-carboxamide ribofuranoside; AMP-activated protein kinase; skeletal muscle
| |
INTRODUCTION |
|---|
|
|
|---|
CHAUVEAU AND KAUFMAN (9) in 1887 reported that when a horse chews on hay the concentration of glucose in the blood draining its masseter muscle substantially decreases. This remarkable observation was the first demonstration that glucose uptake by muscle is enhanced during exercise. In 1924, Sir Henry Dale in England (6) and Carl and Gerti Cori in the United States (11) demonstrated with their colleagues that insulin also increases glucose uptake by muscle. This review will focus on the interaction between insulin and exercise in regulating glucose uptake and in particular will focus on the question of whether a prior bout of exercise enhances the ability of insulin to stimulate glucose utilization by an effect on insulin signaling. For additional discussions of aspects of this subject and of the signaling changes induced in muscle by exercise per se, the reader is referred to a recent paper by Richter et al. (46) and to an earlier review in this series by Goodyear and Sakamoto (19).
| |
ORIGIN OF THE NOTION THAT A PRIOR BOUT OF EXERCISE ACUTELY ENHANCES INSULIN ACTION ON MUSCLE |
|---|
|
|
|---|
The first clue that exercise might enhance the ability of insulin to stimulate muscle glucose utilization was probably provided by Per Bjorntorp and his co-workers in Gothenberg, Sweden in the early 1970s. In 1972 (3), they reported that glucose tolerance was better and plasma insulin levels lower in middle-aged Swedish men who regularly participated in competitive sports than in age- and weight-matched control men. The same investigators also reported that 6 wk of physical training lowered plasma insulin levels (although it did not affect glucose tolerance) in a group of hyperinsulinemic, obese women (2, 4). Collectively, these results led to the suggestion that regular exercise can increase whole body and presumably muscle insulin sensitivity, a notion subsequently confirmed in rats by Carl Mondon, Constantine Dolkas, and Gerald Reaven at Stanford (37).
Bjorntorp's studies did not address the question of whether the increase in insulin sensitivity associated with physical activity is an acute or a chronic effect of exercise. The fact that adipose tissue mass, fat cell size, and plasma lipids (cholesterol and triglycerides) were lower in the athletes whom they studied than in the control men suggested the latter (3). On the other hand, their observation that acute decreases in plasma insulin could persist for several days after each individual exercise bout suggested the former (4). This question aside, Bjorntorp's research encouraged several groups to examine the effect of several months of regular exercise on glucose tolerance in patients with Type 2 diabetes, a disorder associated with insulin resistance. In the first of these studies, reported in 1979, Bengt Saltin and co-workers in Sweden (49) and Neil Ruderman and his colleagues at the Joslin research Laboratory in Boston (48) found modest improvements in glucose tolerance in patients with chemical diabetes (impaired glucose tolerance) and diet-controlled Type 2 diabetes, respectively. On the other hand, the relative transience of the improvement (it had disappeared by 8 days after the last exercise bout) found by the Ruderman group led them to question whether it was the result of a long-term effect of training, such as improved fitness. This and their subsequent finding that hemoglobin A1C levels can be markedly diminished by regular exercise in similar patients with Type 2 diabetes (51) led them to assess the effect of a single bout of exercise on insulin action in skeletal muscle.
In studies that they carried out at Boston University, Erik Richter and
co-workers (47) used the isolated perfused rat hindquarter preparation to demonstrate that the ability of a physiological concentration of insulin (75 µU/ml) to stimulate glucose uptake and
glycogen synthesis in muscle is enhanced for several hours after a
45-min treadmill run (Table 1). They
showed that this effect is restricted to muscles that had performed
work, as judged by glycogen depletion (47), and that it
was reproduced when hindquarter muscle was made to contract by
electrical stimulation of the sciatic nerve. Antonio Zorzano et al.
(62), working in the same laboratory, later showed that
prior exercise enhances the ability of insulin to stimulate
-aminoisobutyrate uptake by muscle, indicating that it also
acts on the Na+-dependent A system for amino acid
transport. In 1990, Greg Cartee et al. (15), in
the laboratory of John Holloszy at Washington University in St. Louis,
reported that the period of increased insulin sensitivity postexercise
could be greatly prolonged if the rats were fasted or fed a
low-carbohydrate diet, a finding that they attributed to these
nutritional manipulations slowing the repletion of muscle glycogen
stores. That prior exercise enhances insulin-stimulated glucose
utilization in human muscle was first reported in 1987 by John Devlin
and Edward Horton at the University of Vermont (13).
|
Armed, in part, with the initial data from Richter's rodent studies, Stephen Schneider and co-workers at the New Jersey College of Medicine and Boston University School of Medicine (50) carried out studies suggesting that the decrease in hemoglobin A1C in patients with Type 2 diabetes caused by physical training is due to the cumulative effect of the individual exercise bouts rather than improved fitness. More specifically, in patients who experienced decreases of hemoglobin A1C in excess of 1% after several months of physical training, Schneider et al. showed that glucose tolerance was substantially better at 12 and 17 h than at 72 h after the last bout of exercise. Concurrent studies in nondiabetic athletes by Heath et al. in Holloszy's laboratory (23) and by Burstein and Posner and colleagues at McGill (7), demonstrating that the high insulin sensitivity of trained individuals diminishes rapidly (days) when these individuals cease exercising, strongly supported this conclusion.
In summary, these early reports established beyond question that a single bout of exercise enhances the sensitivity and responsiveness of skeletal muscle to insulin in both humans and experimental animals. They suggested that both glucose and amino acid transport are affected and that the effect of exercise is mediated in great measure by local rather than systemic factors. They also suggested that much of the apparent benefit of physical training on glycemic control and insulin sensitivity in patients with Type 2 diabetes is attributable to a residual effect of the last bout of exercise. As will be discussed later, however, cumulative effects of regular exercise in these patients almost certainly also play a major role.
| |
EFFORTS TO EXPLAIN AT A MOLECULAR LEVEL HOW PRIOR EXERCISE ENHANCES INSULIN-STIMULATED GLUCOSE TRANSPORT IN MUSCLE |
|---|
|
|
|---|
Insulin signaling.
The demonstration that prior exercise enhances certain actions of
insulin in skeletal muscle (47) took place at the same time that the early steps in the insulin-signaling cascade were being
elucidated (32). For this reason, repeated efforts were made over the next 15 years to determine whether prior exercise alters
the ability of insulin to stimulate one or more signaling events (see
Fig. 1). Initial studies by Arend
Bonen and co-workers in Canada (5) and by Zorzano et al.
(62) established that prior exercise does not increase
insulin binding to its receptor in rat skeletal muscle. Subsequently,
Judith Treadway and David James, also in the Ruderman group
(53), showed that the enhanced biological effects of
insulin after exercise (treadmill run for 45 min) are not paralleled by
increases in either basal or insulin-stimulated tyrosine kinase
activity or autophosphorylation of the insulin receptor. Laurie
Goodyear at the Joslin Research Laboratory and colleagues
(17) and Jorgen Wojtaszewski and colleagues
(57), working jointly with Goodyear and Erik Richter, now
at the Krogh Institute in Copenhagen, extended these findings in rat
and human skeletal muscle, respectively. Paradoxically, they found that contraction caused a decrease in insulin-stimulated tyrosine
phosphorylation (by 20-25%) and insulin response sequence (IRS)-1
immunoprecipitated phosphatidylinositol 3-kinase (PI3-kinase) activity.
In addition, they found that prior exercise did not enhance the ability
of insulin to induce changes in Akt or glycogen synthase kinase
(GSK)-3 in human muscle (57). In contrast, Zhou
and Dohm (59a) found that prior exercise increases the
ability of insulin to stimulate phosphotyrosine immunoprecipitable
PI3-kinase activity, and, more recently, Howlett et al.
(27a), working in the Goodyear laboratory, observed an
increase in IRS-2-associated PI3-kinase activity under these
conditions. Likewise, an increase in insulin-stimulated Akt activity
postexercise has been reported in mice by the latter group
(58a).
|
Recruitment of GLUT-4 glucose transporters to the plasma membrane. Although exercise does not activate the same early events in the insulin-signaling cascade in skeletal muscle as insulin, it also stimulates glucose uptake by enhancing the translocation of GLUT-4 glucose transporters from an intracellular location to the cell surface. The first evidence for this was obtained from measurements of the subcellular distribution of GLUT-4 glucose transporters after acute exercise in rat skeletal muscle by Edward Horton's group at the University of Vermont and Harriet Wallberg-Henriksson at the Karolinska Institute of Sweden (24) and by Holloszy's laboratory working in conjunction with Amira Klip at the University of Toronto (14). The laboratories of Holloszy (34), Morris Birnbaum at the University of Pennsylvania (59), and Steen Lund and Oluf Pedersen (35) at Aarhus University Hospital in Denmark later showed that such glucose transporter recruitment could occur even when activation of PI3-kinase, which is required for the stimulation of glucose transport by insulin, is inhibited by wortmannin. These important findings proved conclusively that exercise and insulin trigger GLUT-4 translocation in muscle by effects on different signaling mechanisms. However, they did not rule out the possibility that insulin and exercise stimulate some common downstream signaling event.
Historically, one hypothesis put forth to explain the postexercise increase in insulin-stimulated glucose transport relates to the possibility that insulin and exercise stimulate the translocation of GLUT-4 from different pools. If this occurred, insulin could act on a larger number of transporters after exercise or it could act on transporters with different properties. The notion of distinct intracellular insulin- and exercise-recruitable GLUT-4 pools in skeletal muscle was first proposed by Amira Klip and co-workers (15) at the University of Toronto, based on analyses of isolated intracellular membranes and plasma membranes from control, exercised, and acutely insulin-treated rats. Subsequent to this, Lise Coderre (10) in Paul Pilch's laboratory at Boston University was the first to isolate and characterize biochemically intracellular insulin and exercise-recruitable GLUT-4 populations from rat skeletal muscle by using fractions separated by discontinuous sucrose density-gradient centrifugation. She found that the two transporter populations had the same protein composition but that they differed in their densities and sedimentation coefficients. The most definitive evidence for distinct insulin and exercise-recruitable GLUT-4 pools, however, was reported in 1998 by Torkil Ploug at the Muscle Research Center of the University of Copenhagen, working in collaboration with Samuel Cushman and Evelyn Ralston at the National Institutes of Health (44). In an elegant set of experiments, they first demonstrated by immunofluorescence microscopy and immunogold electron microscopy that intracellular GLUT-4 vesicles are either positive or negative for the transferrin receptor. They then proceeded to show that only the transferrin receptor-positive vesicles were recruited by contractions. Later studies by Eva Tomás in Zorzano's laboratory at the University of Barcelona suggested that both of these pools (insulin and exercise) are derived from an endosomal compartment (52). Thus the evidence for distinct exercise and insulin recruitable pools is reasonably strong. Whether their presence will help explain the postexercise increase in insulin-stimulated glucose transport remains to be determined. To answer this question will almost certainly require fundamental information about the distal signals by which insulin and exercise trigger GLUT-4 vesicle recruitment from intracellular populations, the docking of these vesicles, and their fusion with cell surface membranes. Finally it has also been suggested that exercise could increase glucose uptake by enhancing the synthesis of GLUT-4 at the level of transcription. Thus studies from Dohm's laboratory (39) have shown that a single bout of exercise can moderately increase GLUT-4 mRNA in previously untrained (1.4-fold) and trained rats for 3 h (1.8-fold) after a single bout of exercise. Likewise, Ren et al. working in Holloszy's laboratory (45) found a 50% increase in GLUT-4 protein and a twofold increase in GLUT-4 mRNA 16 h after a single bout of swimming exercise. Thus exercise clearly also acutely induces signals that lead to an increased expression of GLUT-4 mRNA and protein. As with its effect on GLUT-4 translocation, the precise identity of these signals is not known. For additional information on this and other material covered in this section, the reader is referred to a number of excellent recent reviews (18, 26, 30, 46, 56).| |
AMP-ACTIVATED PROTEIN KINASE |
|---|
|
|
|---|
A major advance in understanding at a molecular level how
contraction affects glucose transport in the muscle cell was the discovery of AMP-activated protein kinase (AMPK). This heterotrimeric enzyme, which contains distinct
-,
-, and
-subunits, is
regulated by changes in a cell's energy state and possibly other
factors. As first characterized in liver by David Carling and D. Graham Hardie (21) at the University of Dundee in Scotland,
increases in the AMP-to-ATP or creatine-to-creatine phosphate ratios of a cell, such as those that occur in response to ischemia and
other stresses, can activate AMPK by several mechanisms. The activation of AMPK, in turn, sets in motion a number of events that both increase
ATP generation (e.g., increased fatty acid oxidation) and decrease ATP
utilization for processes not required for a cells immediate viability
(e.g., inhibition of cholesterol and fatty acid synthesis).
The first indication that AMPK could be involved in the regulation of
muscle metabolism was reported by William Winder at Brigham Young
University in Utah in a joint effort with Hardie (55).
They demonstrated that treadmill running increased AMPK activity in red
quadriceps muscle of a rat by two- to threefold within 5 min. They also
showed that this increase in activity persisted for as long as the rat
continued to run and that it was associated with decreases in the
activity of acetyl-CoA carboxylase and the concentration of
malonyl-CoA, an allosteric inhibitor of carnitine palmitoyl
transferase, the enzyme that controls the transfer of long-chain fatty
acyl CoA into mitochondria where they are oxidized. Subsequently,
Demetrios Vavvas and co-workers in the Ruderman laboratory
(54) and Winder et al. (55) reported similar
changes in response to muscle contraction induced by sciatic nerve
stimulation. Vavvas et al. also showed that activation of AMPK in this
setting involved the
2-isoform that it was evident within seconds and that after 5 min of intense contraction it could
persist for >1 h.
A specific role for AMPK in the regulation of glucose uptake was demonstrated in 1997 by Winder and co-workers (36). Using an isolated rat hindquarter preparation, they showed that perfusion with the AMPK activator 5-aminoimidazole-4-carboxamide ribofuranoside (AICAR) increased glucose uptake by approximately twofold. Subsequent studies carried out jointly by the Goodyear and Winder laboratories established that this effect of AICAR was due to increased glucose transport, that it involved GLUT-4 translocation (33), and that, like the increase in glucose transport induced by muscle contraction, it was not blocked when PI3-kinase is inhibited by wortmannin (22). Likewise, chronic AICAR therapy has been shown by Winder's laboratory to increase GLUT-4 protein in muscle (as does exercise) in vivo (25). A similar effect, as well as an increase in GLUT-4 mRNA has been demonstrated by Holloszy et al. (41) in epitrochlearis muscle incubated for 24 h with AICAR. Despite its array effects on GLUT-4, the precise mechanism by which AMPK activation stimulates glucose transport is still unknown. On the other hand, the molecular events activated in a cell by AICAR in vitro should be easier to characterize than those induced by muscle contraction in vivo. For this reason, AICAR or other pharmacological AMPK activators may prove to be useful tools in determining how prior exercise enhances insulin action in muscle. In this context, Fisher and Nolte (16), working in Holloszy's laboratory, have recently shown that both prior exposure to AICAR and prior tetanic contraction enhance the ability of insulin to stimulate glucose transport in an incubated epitrochlearis muscle. They also found that early and intermediate events in the insulin-signaling pathway (e.g., PI3-kinase activation) were not involved. Thus AMPK, like exercise, appears to work downstream or independently of PI3-kinase to improve insulin sensitivity.
Finally, recent studies by Birnbaum's laboratory (38) have shown that expression of a dominant inhibitory mutant of AMPK completely blocks the ability of hypoxia or AICAR to activate glucose uptake, although only partially reducing contraction-stimulated glucose uptake in skeletal muscle. These authors suggested that "AMPK transmits a portion of the signal by which muscle contraction increases glucose uptake, but other AMPK-independent pathways also contribute to the response."
| |
SUBJECTS FOR FURTHER STUDY |
|---|
|
|
|---|
The effects of prior exercise on insulin-resistant muscle.
This review has focused on the effects of an acute bout of exercise on
insulin action and signaling in normal skeletal muscle. However, from a
clinical perspective, the effects of prior exercise are most likely to
be relevant in muscle that is insulin resistant. Insulin resistance has
been defined as an impaired ability of a given amount of insulin to
exert its usual biological effect and could be related to a decrease in
insulin sensitivity or responsiveness. It has long been appreciated
that muscle of patients with Type 2 diabetes, or at risk for developing
it, are insulin resistant (12). It was for this reason
that regular physical activity was first considered for the therapy and
prevention of Type 2 diabetes (37, 49). Despite this,
investigations of the effect of a prior bout of exercise on insulin
action in insulin-resistant muscle have been few. A potentially
important study was carried out by Nicholas Oakes et al.
(40), working in E. W. Kraegen's laboratory at the
Garvan Institute in Sydney, Australia. In rats made insulin resistant
by ingestion of a eucaloric, high-fat diet for 3 wk, they found that a
single bout of exercise (24 h earlier) substantially reversed the
impaired ability of insulin to stimulate glucose uptake into muscle
during a euglycemic hyperinsulinemic clamp. They also found that the
improvement in insulin sensitivity after exercise was associated with
decreases in the concentrations of long-chain fatty acyl CoA and
malonyl CoA. In a subsequent study, Kim Bell et al. (1) in
the same laboratory found that prior exercise also reversed an increase
in membrane-associated protein kinase C-
in muscle of fat-fed rats.
Although insulin signaling is altered in muscle of these rats
(60), the effect of exercise on these signaling
abnormalities has not been studied.
Effects of a single bout of exercise vs. those of physical training. As already noted, the increased insulin sensitivity of muscle in physically trained humans disappears rapidly (48-72 h) once they stop exercising, suggesting it is in large part related to the last bout of physical activity. On the other hand, physical training diminishes adiposity, fat cell size, and plasma insulin levels (3) and increases the expression of GLUT-4 in muscle (61), all of which could hypothetically enhance the ability of a given amount of insulin to stimulate glucose transport. Thus the relative importance of individual exercise bouts vs. chronic effects of physical training in enhancing insulin action remains unsettled.
As already noted, improvements in glucose tolerance were observed over 20 years ago in response to physical training in patients with Type 2 diabetes. Several years later, complete normalization of glucose tolerance and high plasma insulin levels were observed after 1 yr of intense training by Holloszy and co-workers (27), and more recently increased physical activity has been shown to diminish progression from impaired glucose tolerance to Type 2 diabetes by Pan et al. (42). Despite these impressive clinical findings, investigations of the effects of physical training on insulin signaling in muscle of trained humans and experimental animals have yielded inconsistent results. For further discussion of the effects of physical training on insulin action in humans and experimental animals, and in particular subjects with Type 2 diabetes and/or insulin resistance, the reader is referred to a number of recent reviews (18, 26, 46, 56) and several chapters in the recently published Handbook of Exercise in Diabetes (47a).Effect of exercise on cells other than those in skeletal muscle. Another question for future study is whether exercise enhances insulin signaling in cells other than the skeletal muscle myocyte. Such cells could be present in the arterial wall. Thus insulin resistance, as manifest by impaired activation of PI3-kinase and Akt by insulin, has been found in the aorta of a hyperinsulinemic obese fa/fa (Zucker) rat by George King and co-workers at the Joslin Research Laboratory (31). In addition, Yasuo Ido, David Carling, and Neil Ruderman at Boston University and Hammersmith Hospital in England (29) have shown that the ability of insulin to activate Akt in cultured human umbilical vein endothelial cells is depressed after 24 h of incubation in a hyperglycemic (30 mM glucose) medium. Relevant to this review, they found that this impairment in insulin signaling caused by hyperglycemia was prevented when the human umbilical vein endothelial cells were concurrently incubated with AICAR, an activator of AMPK. Whether exercise causes a similar increase in AMPK in the endothelial cell, in vivo, and if so whether this contributes to its ability to diminish cardiovascular disease in humans (47a) is clearly a subject for further study.
| |
CONCLUDING REMARKS |
|---|
|
|
|---|
The subject of exercise and insulin signaling is somewhat unusual for a historical review, since the first key observations are barely 20 years old and papers published in the past year are also discussed. Despite this, it is increasingly clear that lifestyle changes that include physical activity will very likely play an increasing role in the prevention and treatment of Type 2 diabetes and other diseases associated with insulin resistance. In addition, it is equally clear that an understanding at a molecular level (e.g., insulin signaling) of how exercise diminishes insulin resistance and prevents cellular damage and/or dysfunction will be critical to the success of this effort.
| |
ACKNOWLEDGEMENTS |
|---|
This work was supported in part by National Institute of Diabetes and Digestive and Kidney Diseases Grants DK-19514 and DK-49147, a Mentor Based Fellowship award from the American Diabetes Association, and a Center Grant for the Study of Diabetic Complications from the Juvenile Diabetes Research Foundation.
| |
FOOTNOTES |
|---|
Address for reprint requests and other correspondence: N. B. Ruderman, Diabetes Unit, Section of Endocrinology, Boston Medical Center and Dept. of Medicine, Boston Univ. School of Medicine, 650 Albany St., X-825, Boston, MA 02118 (E-mail: nruderman{at}medicine.bu.edu).
10.1152/japplphysiol.00267.2002
| |
REFERENCES |
|---|
|
|
|---|
1.
Bell, KS,
Schmitz-Peiffer C,
Lim-Fraser M,
Biden TJ,
Cooney GJ,
and
Kraegen EW.
Acute reversal of lipid-induced muscle insulin resistance is associated with rapid alteration in PKC-
localization.
Am J Physiol Endocrinol Metab
279:
E1196-E1201,
2000.
2.
Bjorntorp, P,
De Jounge K,
Sjostrom L,
and
Sullivan L.
The effect of physical training on insulin production in obesity.
Metabolism
19:
631-638,
1970.
3.
Björntorp, P,
Fahlen M,
and
Grimby G.
Carbohydrate and lipid metabolism in middle-aged physically well-trained men.
Metabolism
21:
1037-1044,
1972.
4.
Björntorp, P,
Fahlen M,
Grimby G,
Holm J,
Schensten T,
and
Sjostrom L.
The effects of physical training and acute physical work on plasma insulin in obesity.
Eur J Clin Invest
2:
274-278,
1972.
5.
Bonen, A,
Hood DA,
Tan MH,
Sopper MM,
and
Begin-Heick N.
Insulin binding in human skeletal muscle.
Biochim Biophys Acta
801:
171-176,
1984.
6.
Burn, JH,
and
Dale HH.
On the location of the action of insulin.
J Physiol
59:
164-192,
1924.
7.
Burstein, R,
Polychronakos C,
Toews CJ,
MacDougall JD,
Guyda HJ,
and
Posner BI.
Acute reversal of the enhanced insulin action in trained athletes: association with insulin receptor changes.
Diabetes
34:
756-760,
1985.
8.
Cartee, GD,
Young DA,
Sleeper MD,
Zierath J,
Wallberg-Henriksson H,
and
Holloszy JO.
Prolonged increase in insulin-stimulated glucose transport in muscle after exercise.
Am J Physiol Endocrinol Metab
256:
E494-E499,
1989.
9.
Chauveau, A,
and
Kaufmann M.
Expériences pour la determination du coefficient de l'activité nutritive et respiratoire des muscles en respos et en travail.
Compt Rend Ac Sci
104:
1126-1132,
1887.
10.
Coderre, L,
Kandror KV,
Vallega G,
and
Pilch PF.
Identification and characterization of an exercise-sensitive pool of glucose transporters in skeletal muscle.
J Biol Chem
270:
27584-27588,
1995.
11.
Cori, CF,
Cori GT,
and
Goltz HL.
Comparative study of the blood sugar concentration in the liver vein, the leg artery and the leg vein during insulin action.
J Pharmacol Exp Ther
22:
355-373,
1924.
12.
De Fronzo, RA.
Lilly lecture 1987. The triumvirate:
-cell, muscle, liver. A collusion responsible for NIDDM.
Diabetes
37:
667-687,
1988.
13.
Devlin, JT,
Hirshman MF,
Horton ES,
and
Horton ED.
Enhanced peripheral insulin and spanchnic insulin sensitivity in NIDDM after single bout of exercise.
Diabetes
36:
434-439,
1987.
14.
Douen, AG,
Ramlal T,
Klip A,
Young DA,
Cartee GD,
and
Holloszy JO.
Exercise-induced increase in glucose transporters in plasma membranes of rat skeletal muscle.
Endocrinology
124:
449-454,
1989.
15.
Douen, AG,
Ramlal T,
Rastogi S,
Bilan PJ,
Cartee GD,
Vranie M,
Holloszy JO,
and
Klip A.
Exercise induces recruitment of the "insulin-responsive transporter." Evidence for distinct intracellular insulin-and exercise-recruitable transporter pools in skeletal muscle.
J Biol Chem
265:
13427-13430,
1990.
16.
Fisher, JS,
Gao J,
Han DH,
Holloszy JO,
and
Nolte LA.
Activation of AMP kinase enhances sensitivity of muscle glucose transport to insulin.
Am J Physiol Endocrinol Metab
282:
E18-E23,
2002.
17.
Goodyear, LJ,
Giorgino F,
Balon TW,
Condorelli G,
and
Smith RJ.
Effects of contractile activity on tyrosine phosphoproteins and PI3-kinase activity in rat skeletal muscle.
Am J Physiol Endocrinol Metab
268:
E987-E995,
1995.
18.
Goodyear, LJ,
and
Kahn BB.
Exercise, glucose transport, and insulin sensitivity.
Annu Rev Med
49:
235-261,
1998.
19.
Goodyear, LJ,
and
Sakamoto K.
Invited Review: Intracellular signaling in contracting skeletal muscle.
J Appl Physiol
93:
369-383,
2002.
21.
Hardie, DG,
and
Carling D.
The AMP-activated protein kinase. Fuel gauge of the mammalian cell?
Eur J Biochem
246:
259-273,
1997.
22.
Hayashi, T,
Hirshman MF,
Kurth EJ,
Winder WW,
and
Goodyear LJ.
Evidence for 5'-AMP-activated protein kinase mediation of the effect of muscle contraction on glucose transport.
Diabetes
47:
1369-1373,
1998.
23.
Heath, GW,
Gavin JR, 3rd,
Hinderliter JM,
Hagberg JM,
Bloomfield SA,
and
Holloszy JO.
Effects of exercise and lack of exercise on glucose tolerance and insulin sensitivity.
J Appl Physiol
55:
512-517,
1983.
24.
Hirshman, MF,
Wallberg-Henrikson H,
Wardzala LJ,
Horton ED,
and
Horton ES.
Acute exercise increases the number of plasma membrane glucose transporters in rat skeletal muscle.
FEBS Lett
238:
235-239,
1988.
25.
Holmes, BF,
Kurth-Kraczek EJ,
and
Winder WW.
Chronic activation of 5'-AMP-activated protein kinase increases GLUT4, hexokinase, and glycogen in muscle.
J Appl Physiol
87:
1990-1995,
1999.
26.
Holloszy, JO,
and
Hansen PA.
Regulation of glucose transport into skeletal muscle.
Rev Physiol Biochem Pharmacol
128:
99-193,
1996.
27.
Holloszy, JO,
Schultz J,
Kusnierkiewicz J,
Hagberg JM,
and
Ehsani AA.
Effects of exercise on glucose tolerance and insulin resistance. Brief review and some preliminary results.
Acta Med Scand Suppl
711:
55-65,
1986.
27a.
Howlett, F,
Sakamato K,
Aschenbach WG,
Dow M,
White MF,
and
Goodyear L.
Insulin signaling after exercise in insulin receptor substrate-2-deficient mice.
Diabetes
51:
479-483,
2002.
28.
Hutber, CA,
Hardie DG,
and
Winder WW.
Electrical stimulation inactivates muscle acetyl-CoA carboxylase and increases AMP-activated protein kinase.
Am J Physiol Endocrinol Metab
272:
E262-E266,
1997.
29.
Ido, Y,
Carling D,
and
Ruderman NB.
Hyperglycemia-induced apoptosis in human umbilical vein endothelial cells: inhibition by the AMP-activated protein kinase activation.
Diabetes
51:
159-167,
2002.
30.
Ivy, JL.
Role of exercise training in the prevention and treatment of insulin resistance and non-insulin-dependent diabetes mellitus.
Sports Med
24:
321-336,
1997.
31.
Jiang, ZY,
Lin YW,
Clemont A,
Feener EP,
Hein KD,
Igarashi M,
Yamauchi T,
White MF,
and
King GL.
Characterization of selective resistance to insulin signaling in the vasculature of obese Zucker (fa/fa) rats.
J Clin Invest
104:
447-457,
1999.
32.
Kasuga, M,
Karlsson FA,
and
Kahn CR.
Insulin stimulates the phosphorylation of the 95,000-dalton subunit of its own receptor.
Science
215:
185-187,
1982.
33.
Kurth-Kraczek, EJ,
Hirshman MF,
Goodyear LJ,
and
Winder WW.
5' AMP-activated protein kinase activation causes GLUT4 translocation in skeletal muscle.
Diabetes
48:
1667-1671,
1999.
34.
Lee, AD,
Hansen PA,
and
Holloszy JO.
Wortmannin inhibits insulin-stimulated but not contraction-stimulated glucose transport activity in skeletal muscle.
FEBS Lett
361:
51-54,
1995.
35.
Lund, S,
Holman GD,
Schmitz O,
and
Pedersen O.
Contraction stimulates translocation of glucose transporter GLUT4 in skeletal muscle through a mechanism distinct from that of insulin.
Proc Natl Acad Sci USA
92:
5817-5821,
1995.
36.
Merrill, GF,
Kurth EJ,
Hardie DG,
and
Winder WW.
AICA riboside increases AMP-activated protein kinase, fatty acid oxidation, and glucose uptake in rat muscle.
Am J Physiol
5:
95-113,
1997.
37.
Mondon, CE,
Dolkas CB,
and
Reaven GM.
Site of enhanced insulin sensitivity in exercise-trained rats at rest.
Am J Physiol Endocrinol Metab
239:
E169-E177,
1980.
38.
Mu, J,
Brozinick JT, Jr,
Valladares O,
Bucan M,
and
Birnbaum MJ.
A role for AMP-activated protein kinase in contraction- and hypoxia-regulated glucose transport in skeletal muscle.
Mol Cell
7:
1085-1094,
2001.
39.
Neufer, PD,
and
Dohm L.
Exercise induces a transient increase in transcription of the GLUT-4 gene in skeletal muscle.
Am J Physiol Cell Physiol
265:
C1597-C1603,
1993.
40.
Oakes, ND,
Bell KS,
Furler SM,
Camilleri S,
Saha AK,
Ruderman NB,
Chisholm DJ,
and
Kraegen EW.
Diet-induced muscle insulin resistance in rats is ameliorated by acute dietary lipid withdrawal or a single bout of exercise: parallel relationship between insulin stimulation of glucose uptake and suppression of long-chain fatty acyl-CoA.
Diabetes
46:
2022-2028,
1997.
41.
Ojuka, EO,
Nolte LA,
and
Holloszy JO.
Increased expression of GLUT-4 and hexokinase in rat epitrochlearis muscles exposed to AICAR in vitro.
J Appl Physiol
88:
1072-1075,
2000.
42.
Pan, XR,
Li GW,
Hu YH,
Wang JX,
Yang WY,
An ZX,
Hu ZX,
Lin J,
Xiao JZ,
Cao HB,
Liu PA,
Jiang XG,
Jiang YY,
Wang JP,
Zheng H,
Zhang H,
Bennett PH,
and
Howard BV.
Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance: the Da Qing IGT and Diabetes Study.
Diabetes Care
20:
537-544,
1997.
43.
Pessin, JE,
and
Saltiel AR.
Signaling pathways in insulin action: molecular targets of insulin resistance.
J Clin Invest
106:
165-169,
2000.
44.
Ploug, T,
van Deurs B,
Ai H,
Cushman SW,
and
Ralston E.
Analysis of GLUT4 distribution in whole skeletal muscle fibers: identification of distinct storage compartments that are recruited by insulin and muscle contractions.
J Cell Biol
142:
1429-1446,
1998.
45.
Ren, JM,
Semenkovich CF,
Gulve FA,
Gao J,
and
Holloszy JO.
Exercise induces rapid increases in GLUT4 expression, glucose transport capacity, and insulin-stimulated glycogen storage in muscle.
J Biol Chem
269:
14396-14401,
1994.
46.
Richter, EA,
Derave W,
and
Wojtaszewski JF.
Glucose, exercise and insulin: emerging concepts.
J Physiol
535:
313-322,
2001.
47.
Richter, EA,
Garetto LP,
Goodman MN,
and
Ruderman NB.
Muscle glucose metabolism following exercise in the rat: increased sensitivity to insulin.
J Clin Invest
69:
785-793,
1982.
47a.
Ruderman, NB,
Devlin JT,
Schneider S,
and
Kriska A
(Editors).
Handbook of Exercise in Diabetes. Alexandria, VA: American Diabetes Association, 2001, chapts. 3 and 8-12.
48.
Ruderman, NB,
Ganda OP,
and
Johansen K.
The effect of physical training on glucose tolerance and plasma lipids in maturity-onset diabetes.
Diabetes
28, Suppl1:
89-92,
1979.
49.
Saltin, B,
Lindgärde F,
Houston M,
Hörlin R,
Nygaard E,
and
Gad P.
Physical training and glucose tolerance in middle-aged men with chemical diabetes.
Diabetes
28, Suppl1:
30-32,
1979.
50.
Schneider, SH,
Amorosa LF,
Khachadurian AK,
and
Ruderman NB.
Studies on the mechanism of improved glucose control during regular exercise in Type 2 (non-insulin dependent) diabetes.
Diabetologia
26:
355-360,
1984.
51.
Schneider, SH,
Ruderman NB,
Amorosa LF,
and
Khachadurian AK.
Physical training of non-insulin dependent diabetics (Abstract).
Diabetes
30, Suppl 1:
A748,
1981.
52.
Tomas, E,
Sevilla L,
Palacin M,
and
Zorzano A.
The insulin-sensitive GLUT4 storage compartment is a postendocytic and heterogeneous compartment recruited by acute exercise.
Biochem Biophys Res Commun
284:
490-494,
2001.
53.
Treadway, JL,
James DE,
Burcel E,
and
Ruderman NB.
Effect of exercise on insulin receptor binding and kinase activity in skeletal muscle.
Am J Physiol Endocrinol Metab
256:
E138-E144,
1989.
54.
Vavvas, D,
Apazidis A,
Saha AK,
Gamble J,
Patel A,
Kemp BE,
Witters LA,
and
Ruderman NB.
Contraction-induced changes in acetyl-CoA carboxylase and 5'-AMP-activated kinase in skeletal muscle.
J Biol Chem
272:
13256-13261,
1997.
55.
Winder, WW,
and
Hardie DG.
Inactivation of acetyl-CoA carboxylase and activation of AMP-activated protein kinase in muscle during exercise.
Am J Physiol Endocrinol Metab
270:
E299-E304,
1996.
56.
Winder, WW,
and
Hardie DG.
AMP-activated protein kinase, a metabolic master switch: possible roles in Type 2 diabetes.
Am J Physiol Endocrinol Metab
277:
E1-E10,
1999.
57.
Wojtaszewski, JF,
Hansen BF,
Gade J,
Kiens B,
Markuns JF,
Goodyear LJ,
and
Richter EA.
Insulin signaling and insulin sensitivity in human skeletal muscle.
Diabetes
49:
325-331,
2000.
58.
Wojtaszewski, JF,
Hansen BF,
Kiens B,
and
Richter EA.
Insulin signaling in human skeletal muscle: time course and effect of exercise.
Diabetes
46:
1775-1781,
1997.
58a.
Wojtaszewski, JFP,
Higaki Y,
Hirshman MF,
Michael MD,
Dufresne SD,
Kahn CR,
and
Goodyear LJ.
Exercise modulates postreceptor insulin signaling and glucose transport in muscle-specific insulin receptor knockout mice.
J Clin Invest
104:
1257-1264,
1999.
59.
Yeh, JI,
Gulve EA,
Rameh L,
and
Birnbaum MJ.
The effects of wortmannin on rat skeletal muscle: dissociation of signaling pathways for insulin- and contraction-activated hexose transport.
J Biol Chem
270:
2107-2111,
1995.
59a.
Zhou, Q,
and
Dohm GL.
Treadmill running increases phosphatidylinositol 3-kinase activity in rat skeletal muscle.
Biochem Biophys Res Commun
236:
647-650,
1997.
60.
Zierath, JR,
Houseknecht KL,
Gnudi L,
and
Kahn BB.
High-fat feeding impairs insulin-stimulated GLUT4 recruitment via an early insulin-signaling defect.
Diabetes
46:
215-223,
1997.
61.
Zierath, JR,
Krook A,
and
Wallberg-Henriksson H.
Insulin action and insulin resistance in human skeletal muscle.
Diabetologia
43:
821-835,
2000.
62.
Zorzano, A,
Balon TW,
Garetto LP,
Goodman MN,
and
Ruderman NB.
Muscle
-aminoisobutyric acid transporter after exercise: enhanced stimulation by insulin.
Am J Physiol Endocrinol Metab
248:
E546-E552,
1985.
This article has been cited by other articles:
![]() |
K. F. Howlett, K. Sakamoto, A. Garnham, D. Cameron-Smith, and M. Hargreaves Resistance Exercise and Insulin Regulate AS160 and Interaction With 14-3-3 in Human Skeletal Muscle Diabetes, June 1, 2007; 56(6): 1608 - 1614. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. O. Holloszy A forty-year memoir of research on the regulation of glucose transport into muscle Am J Physiol Endocrinol Metab, March 1, 2003; 284(3): E453 - E467. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Tomas, T.-S. Tsao, A. K. Saha, H. E. Murrey, C. c. Zhang, S. I. Itani, H. F. Lodish, and N. B. Ruderman Enhanced muscle fat oxidation and glucose transport by ACRP30 globular domain: Acetyl-CoA carboxylase inhibition and AMP-activated protein kinase activation PNAS, December 10, 2002; 99(25): 16309 - 16313. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |